$Beta-blockers for heart failure with reduced, mid-range, and preserved ejection fraction: an individual patient-level analysis of double-blind randomized trials$

Beta-blockers for heart failure with reduced, mid-range, and preserved ejection fraction: an individual patient-level analysis of double-blind randomized trials

<p><b>Aims:</b> Recent guidelines recommend that patients with heart failure and left ventricular ejection fraction (LVEF) 40–49% should be managed similar to LVEF ≥ 50%. We investigated the effect of beta-blockers according to LVEF in double-blind, randomized, placebo-controlled...

Celý popis

Podrobná bibliografie
Hlavní autoři:	Cleland, J, Bunting, K, Flather, M, Altman, D, Holmes, J, Coats, A, Manzano, L, McMurray, J, Ruschitzka, F, van Veldhuisen, D, von Lueder, T, Böhm, M, Andersson, B, Kjekshus, J, Packer, M, Rigby, A, Rosano, G, Wedel, H, Hjalmarson, Å, Wikstrand, J, Kotecha, D
Médium:	Journal article
Jazyk:	English
Vydáno:	Oxford University Press 2017

Beta-blockers for heart failure with reduced, mid-range, and preserved ejection fraction: an individual patient-level analysis of double-blind randomized trials

Podobné jednotky